Current:Home > FinanceSurpassing Quant Think Tank Center|Inmate awaiting execution says South Carolina didn’t share enough about lethal injection drug -Wealth Evolution Experts
Surpassing Quant Think Tank Center|Inmate awaiting execution says South Carolina didn’t share enough about lethal injection drug
EchoSense Quantitative Think Tank Center View
Date:2025-04-08 22:33:03
COLUMBIA,Surpassing Quant Think Tank Center S.C. (AP) — Lawyers for the South Carolina inmate scheduled to be put to death later this month said Tuesday state prison officials didn’t provide enough information about the drug to decide whether he wants to die by lethal injection.
Freddie Owens’ attorneys want prison administrators to provide the actual report from state scientists who tested the sedative pentobarbital. The state provided just a summary that said the drug is stable, pure and — based on similar methods in other jurisdictions — potent enough to kill.
Attorneys for the state have argued a shield law passed in 2023 keeps many details about the drug private because they could be used to track the compounding pharmacy that made it.
South Carolina hasn’t put an inmate to death since 2011 in part because the state struggled to get a company to sell or make the drugs needed for a lethal injection out of fear of being publicly identified.
How much information should be released to a condemned inmate is one of several pending legal issues before the South Carolina Supreme Court as Owens’ execution date nears. He is scheduled to be put to death Sept. 20 for shooting a Greenville convenience store clerk in the head during a 1997 robbery.
His lawyers last week asked for a delay, saying Owens’ co-defendant lied about having no plea deal and possibly facing the death penalty in exchange for his testimony. Steven Golden ended up with a 28-year sentence in a case where no evidence was presented about who fired the fatal shot beyond Golden’s testimony that Owens killed the clerk because she struggled to open the store’s safe.
Owens’ attorneys want more time to argue he deserves a new trial because of new evidence, including a juror saying they were able to see a stun belt Owens had to wear to assure good behavior during his trial.
The state Supreme Court ruled Tuesday that Owens can allow his lawyer to decide the method of execution. Owens said physically signing the form would be like suicide and a sin in his Muslim faith because he would take an active role in his own death.
Owens, 46, faces a Friday deadline to let prison officials know if he chooses to die by lethal injection, electrocution or the new firing squad. If he doesn’t choose he would go to the electric chair.
That decision can’t be fairly made without more information about the lethal injection drug, part of a new one-drug protocol the state is using, Owens’ attorney Gerald King Jr. wrote in court papers.
Instead, King wants to see the full report from the State Law Enforcement Division laboratory that tested the pentobarbital. He said the technicians’ names can be redacted under the shield law.
Included in court papers was a sworn statement from a University of South Carolina pharmacy professor saying the details provided by prison officials weren’t enough to make an informed decision on whether the lethal injection drug was pure, stable and potent enough to carry out the execution.
“The affidavit does not specify the test methods used, the testing procedures followed, or the actual results obtained from those tests,” Dr. Michaela Almgren wrote in a sworn statement.
The report also said Owens wasn’t provided with the date the drugs were tested or the “beyond use date” when a compounded drug becomes unstable. An unstable drug could cause intense pain when injected, damage blood vessels or not be strong enough to kill the inmate, Almgren wrote.
The state didn’t say how the drugs, which are sensitive to temperature, light and moisture, would be stored, Almgren said.
veryGood! (2371)
Related
- Behind on your annual reading goal? Books under 200 pages to read before 2024 ends
- Kia, Volkswagen, Subaru, and Audi among 208,000 vehicles recalled: Check car recalls here
- Grimes Speaks Out About Baby No. 3 With Elon Musk
- Dog walker struck by lightning along Boston beach, critically hospitalized
- Trump suggestion that Egypt, Jordan absorb Palestinians from Gaza draws rejections, confusion
- Elon Musk says he denied Ukraine satellite request to avoid complicity in major act of war vs. Russia
- United States takes on Google in biggest tech monopoly trial of 21st century
- Helton teams up with organization to eliminate $10 million in medical bills for Colorado residents
- Why Sean "Diddy" Combs Is Being Given a Laptop in Jail Amid Witness Intimidation Fears
- Horoscopes Today, September 11, 2023
Ranking
- Jamie Foxx gets stitches after a glass is thrown at him during dinner in Beverly Hills
- Escaped prisoner Danelo Cavalcante seen driving stolen van, visiting former colleague's house, police say
- Police in Jamaica charge a man suspected of being a serial killer with four counts of murder
- Cash bail disproportionately impacts communities of color. Illinois is the first state to abolish it
- Rams vs. 49ers highlights: LA wins rainy defensive struggle in key divisional game
- Julio Urías' locker removed from Dodgers' clubhouse; Dave Roberts says team is moving on
- Drew Barrymore to restart her talk show amid strikes, drawing heated criticism
- Cyberattack shuts down IT systems at MGM hotels in Las Vegas
Recommendation
DeepSeek: Did a little known Chinese startup cause a 'Sputnik moment' for AI?
Sentencing delayed for a New Hampshire man convicted of running an unlicensed bitcoin business
Illinois appeals court to hear arguments on Jussie Smollett request to toss convictions
The search for Cyprus’ missing goes high-tech as time weighs on loved ones waiting for closure
New data highlights 'achievement gap' for students in the US
Amy Poehler, Jimmy Fallon's tense 'SNL' moment goes viral after 'Tonight Show' allegations
Flooding in eastern Libya after weekend storm leaves 2,000 people feared dead
New COVID vaccines get FDA approval